The MADO study of the need, reasons and strategies for dose adjustment in allergen immunotherapy: patient profiles

被引：0
|
作者：
Thetis-Soulie, M. [1 ]
Hosotte, M. [2 ]
Grozelier, I [3 ]
Baillez, C. [4 ]
Scurati, S. [5 ]
Mercier, V [6 ]
机构：
[1] Private Practice, Creteil, France
[2] Gentilly Allergy Ctr, Nancy, France
[3] Private Practice, Cholet, France
[4] Private Practice, Perpignan, France
[5] Stallergenes Greer, Med Affairs, Antony, France
[6] Private Practice, Toulouse, France
来源：
ALLERGY | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
269
引用
收藏
页码：41 / 41
页数：1
相关论文
共 43 条
  • [21] Allergen immunotherapy in Italy: How, when, and why-A real-world study conducted through a patient association
    Paoletti, Giovanni
    Nappi, Emanuele
    Bragato, Maria Chiara
    Valli, Paola
    Giovannini, Mattia
    Gargano, Domenico
    Pecoraro, Luca
    Diso, Deborah
    Barbaglia, Simona
    Canonica, Giorgio Walter
    Heffler, Enrico
    WORLD ALLERGY ORGANIZATION JOURNAL, 2025, 18 (01):
  • [22] HYBRID TIME AND MOTION, PATIENT SURVEY AND CHART REVIEW STUDY METHODOLOGY: A CASE STUDY OF SUBCUTANEOUS ALLERGEN IMMUNOTHERAPY IN THE UNITED STATES AND CANADA
    Yeomans, K.
    Payne, K. A.
    Blume, S. W.
    Tao, S.
    Hubbard, S. M.
    Allen-Ramey, F.
    VALUE IN HEALTH, 2014, 17 (03) : A203 - A203
  • [23] Design of dose range finding study with allergen specific immunotherapy in patients with house dust mite induced allergic rhinitis/rhinoconjunctivitis
    Bachert, C.
    Pfaar, O.
    Roger, A.
    Riechelmann, H.
    Elberink, Oude J.
    Nell, M.
    Boot, J.
    ALLERGY, 2012, 67 : 522 - 523
  • [24] Dose Adjustment During Pollen Seasons in Build-up and Maintenance Vials Lowers the Risk of Severe Systemic Reactions (SRs) to Subcutaneous Allergen Immunotherapy (SCIT): Year 4 of the AAAAI/ACAAI Surveillance Study
    Epstein, Tolly
    Liss, Gary M.
    Berendts, Karen Murphy
    Bernstein, David I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB201 - AB201
  • [25] Strong Dose-response Using a Conjunctival Provocation Test During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen plus MPL
    Ballard, Rachel
    Zielen, Stefan
    Aberer, Werner
    Lassmann, Sabine
    Wade, Anette
    Kluehr, Karolin
    Raab, Jennifer
    Lee, Denise
    Jones, Chris
    Gunawardena, Kulasari
    Kramer, Matthias
    Skinner, Murray A.
    Higenbottam, Tim
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB285 - AB285
  • [26] Strong dose-response using a conjunctival provocation test during a phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
    Zielen, S.
    Aberer, W.
    Lassmann, S.
    Wade, A.
    Kluehr, K.
    Raab, J.
    Lee, D.
    Ballard, R.
    Jones, C.
    Gunawardena, K.
    Kramer, M. F.
    Skinner, M. A.
    Higenbottam, T.
    De Kam, P.
    ALLERGY, 2019, 74 : 78 - 78
  • [27] No need for dose adjustment of GnRH antagonist based on patient's body weight in controlled ovarian hyperstimulation with recombinant follicle stimulating hormone.
    Oberyé, J
    FERTILITY AND STERILITY, 2003, 80 : S9 - S9
  • [28] Tailoring strategies to support the implementation of Dose Adjustment For Normal Eating (DAFNE), a structured patient education programme for people with Type 1 diabetes
    Riordan, Fiona
    Kerins, Claire
    Humphreys, Margaret
    Dinneen, Sean
    Wolfenden, Luke
    McHugh, Sheena M.
    IMPLEMENTATION SCIENCE, 2023, 18
  • [29] Relevant patient benefit of 5-grass pollen tablet allergen immunotherapy (AIT) in grass-pollen allergic adults, adolescents and children with different clinical profiles
    Hadler, M.
    Karagiannis, E.
    Blome, C.
    Kisch, J.
    Augustin, M.
    ALLERGY, 2017, 72 : 507 - 507
  • [30] Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days
    Petersen, Karin D.
    Kronborg, Christian
    Larsen, Jorgen N.
    Dahl, Ronald
    Gyrd-Hansen, Dorte
    WORLD ALLERGY ORGANIZATION JOURNAL, 2013, 6
12345